Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.585
+0.015 (0.96%)
Nov 10, 2025, 9:58 AM EST - Market open
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.88 million as of November 10, 2025. Its market cap has increased by 55.42% in one year.
Market Cap
2.88M
Enterprise Value
-91.09K
1-Year Change
55.42%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $2.88M, a decrease of -95.74%. That is a compound annual growth rate of -54.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 2.85M | 5.86% |
| Dec 31, 2024 | 2.69M | 78.03% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
| Nov 10, 2021 | 67.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |